Literature DB >> 6273877

Purified glucocorticoid receptors bind selectively in vitro to a cloned DNA fragment whose transcription is regulated by glucocorticoids in vivo.

F Payvar, O Wrange, J Carlstedt-Duke, S Okret, J A Gustafsson, K R Yamamoto.   

Abstract

Activated glucocorticoid receptor protein, purified to 40-60% homogeneity from rat liver extracts, binds selectively in vitro to a cloned fragment of murine mammary tumor virus (MTV) DNA. The DNA fragment tested contains about half of the sequences present in intact MTV DNA, and its rate of transcription, like that of the intact viral element, is strongly stimulated by glucocorticoids when it is introduced into the genome of a receptor-containing cell. In contrast, the receptor fails to bind selectively to DNA restriction fragments from E. coli plasmids pBR322 and RSF2124 or from bacteriophages lambda and T4. Preliminary experiments to localize regions within MTV DNA responsible for selective binding have revealed thus far one subfragment that fails to bind the receptor and one selectively bound subfragment that maps far downstream from the 5' terminus of the normal RNA transcript. These studies are consistent with the notion that steroid receptors may modulate rates of transcription by recognizing specific DNA sequences within or near the regulated genes.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6273877      PMCID: PMC349102          DOI: 10.1073/pnas.78.11.6628

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Lac repressor binding to non-operator DNA: detailed studies and a comparison of eequilibrium and rate competition methods.

Authors:  S Y Lin; A D Riggs
Journal:  J Mol Biol       Date:  1972-12-30       Impact factor: 5.469

2.  Estrogen receptor binding to isolated nuclei. A nonsaturable process.

Authors:  G C Chamness; A W Jennings; W L McGuire
Journal:  Biochemistry       Date:  1974-01-15       Impact factor: 3.162

3.  On the specificity of the binding of the estradiol receptor protein to deoxyribonucleic acid.

Authors:  K R Yamamoto; B Alberts
Journal:  J Biol Chem       Date:  1974-11-25       Impact factor: 5.157

4.  Kinetic and equilibrium analysis of estradiol in uterus: a model of binding-site distribution in uterine cells.

Authors:  D Williams; J Gorski
Journal:  Proc Natl Acad Sci U S A       Date:  1972-11       Impact factor: 11.205

5.  In vitro conversion of estradiol-receptor protein to its nuclear form: dependence on hormone and DNA.

Authors:  K R Yamamoto; B M Alberts
Journal:  Proc Natl Acad Sci U S A       Date:  1972-08       Impact factor: 11.205

6.  Multiple repressor binding at the operators in bacteriophage lambda.

Authors:  T Maniatis; M Ptashne
Journal:  Proc Natl Acad Sci U S A       Date:  1973-05       Impact factor: 11.205

7.  Lac repressor-operator interaction. I. Equilibrium studies.

Authors:  A D Riggs; H Suzuki; S Bourgeois
Journal:  J Mol Biol       Date:  1970-02-28       Impact factor: 5.469

8.  A dye-buoyant-density method for the detection and isolation of closed circular duplex DNA: the closed circular DNA in HeLa cells.

Authors:  R Radloff; W Bauer; J Vinograd
Journal:  Proc Natl Acad Sci U S A       Date:  1967-05       Impact factor: 11.205

9.  Integration and activity of mammary tumor virus genes: regulation by hormone receptors and chromosomal position.

Authors:  K R Yamamoto; V L Chandler; S R Ross; D S Ucker; J C Ring; S C Feinstein
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1981

10.  Role of DNA and specific cytoplasmic receptors in glucocorticoid action.

Authors:  J D Baxter; G G Rousseau; M C Benson; R L Garcea; J Ito; G M Tomkins
Journal:  Proc Natl Acad Sci U S A       Date:  1972-07       Impact factor: 11.205

View more
  79 in total

1.  Biography of Jan-Ake Gustafsson.

Authors:  Christen Brownlee
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-09       Impact factor: 11.205

Review 2.  Genomic RNAi screening in Drosophila S2 cells: what have we learned about host-pathogen interactions?

Authors:  Sara Cherry
Journal:  Curr Opin Microbiol       Date:  2008-06-06       Impact factor: 7.934

3.  Transcriptional repression of a hormone-responsive promoter.

Authors:  K L Morley; M G Toohey; D O Peterson
Journal:  Nucleic Acids Res       Date:  1987-09-11       Impact factor: 16.971

4.  Multiple hormone-inducible enhancers as mediators of differential transcription.

Authors:  M G Toohey; K L Morley; D O Peterson
Journal:  Mol Cell Biol       Date:  1986-12       Impact factor: 4.272

5.  Permissive effect of dexamethasone on the increase of proenkephalin mRNA induced by depolarization of chromaffin cells.

Authors:  J R Naranjo; I Mocchetti; J P Schwartz; E Costa
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

6.  A mutation that causes lability of the androgen receptor under conditions that normally promote transformation to the DNA-binding state.

Authors:  W J Kovacs; J E Griffin; D D Weaver; B R Carlson; J D Wilson
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

7.  Two nuclear DNA binding proteins of Dictyostelium discoideum with a high affinity for poly(dA)-poly(dT).

Authors:  H Garreau; J G Williams
Journal:  Nucleic Acids Res       Date:  1983-12-10       Impact factor: 16.971

8.  Human argininosuccinate synthetase minigenes are subject to arginine-mediated repression but not to trans induction.

Authors:  F M Boyce; G M Anderson; C D Rusk; S O Freytag
Journal:  Mol Cell Biol       Date:  1986-04       Impact factor: 4.272

9.  Modulation of the ligand-independent activation of the human estrogen receptor by hormone and antihormone.

Authors:  C L Smith; O M Conneely; B W O'Malley
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

10.  Cloned mouse mammary tumor virus DNA exhibits glucocorticoid-dependent expression in simian virus 40-transformed mink cells.

Authors:  D Owen; H Diggelmann
Journal:  J Virol       Date:  1983-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.